Last reviewed · How we verify
Peptostreptococcus infection
Approved treatments
- Metro I.V. In Plastic Container · Baxter
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Cefotan
- Epocelin
- Rocephin · Generic (originally Roche)
- Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Peptostreptococcus infection patent landscape — cliff calendar, originator estates, attackable patents
- Peptostreptococcus infection treatment landscape brief
- Peptostreptococcus infection treatment updates RSS
Frequently asked questions about Peptostreptococcus infection
What drugs treat Peptostreptococcus infection?
Tracked treatments include Metro I.V. In Plastic Container, Ceftriaxon, Invanz, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan, Epocelin, Rocephin, Metronidazol.
What is the treatment for Peptostreptococcus infection?
Standard treatment for Peptostreptococcus infection includes Metro I.V. In Plastic Container, Ceftriaxon, Invanz, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Peptostreptococcus infection patent cliff · Peptostreptococcus infection CI report
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Invanz · Merck & Co.
- Treatment: Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Treatment: Cefotan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing